This short textbook converted from a research paper was written with the aim of navigating a suitable judicial policy making route for intervention in domains where medical fallacy and the law intersect and, thereby, to give strength to the voice of the common man from a public interest standpoint. The essential study as presented here is specifically in the context of the recent Anuradha Saha judgment, where an astounding eleven crore rupees compensation was awarded to the claimant for the suffering inflicted on his wife that eventually resulted in her tragic demise. The original paper from which this textbook was eventually developed had been presented at the International Conference on Comparative Law and Development in 2014.
Table of Contents
I. Introduction
II. Revolutionizing the present evidential rule of procedure
III. De-limiting the patient’s right to bodily autonomy
IV. Re-designing medicinal practice to equitable innovation
V. Recognizing the need for compliance free package regulations
VI. Conclusion
Research Objectives and Core Themes
This study analyzes the growing impact of malpractice litigation on health care reform in India, specifically investigating the interdependencies between legal outcomes and clinical practice standards in the context of landmark judgments like Dr. Balram Prasad v. Doctor Kunal Saha & Ors.
- Medico-legal analysis of malpractice litigation and reform.
- Evaluation of evidential procedures and the shift from "Bolam" to "Bolitho" standards.
- Patient rights, informed consent, and the doctrine of bodily autonomy.
- Proposals for evidence-based clinical guidelines and regulatory compliance.
- Critical review of current drug trial practices and defensive medicine.
Excerpt from the Book
Chapter II. Revolutionizing the present evidential rule of procedure
One of the most notable observations of the Supreme Court in its judgment on Anuradha Saha’s case is that, in matters of criminal justice, with respect to the victims of medical negligence, a court will not be bound by the evidence of an expert as such evidence is only advisory in nature and that the court must therefore derive its own conclusion. This observation marks a decisive shift from the Bolam standard, which had remained the sole test for determining negligence until now, to the Bolitho standard which is a much newer principle in comparison to the former.
While the Bolam test dictated that the evidence brought out in support of one’s claim of negligent conduct on part of the doctor should have been attestable to a responsible body of medical opinion, the Bolitho test requires the evidence to be susceptible to a process of logical interpretation by the judges. However, this shift towards the acceptance of a new standard, for determining negligence still fails to take into account the feasibility of production of expert medical evidence in a court of law. This feasibility is in question because of the exorbitant expenses that are usually incurred in the process of gathering such evidence as also the inevitable bias that must arise in the testimonies of physicians who may, for all purposes of our presumption, belong to the same fraternity of doctors as the respondent doctor himself.
Summary of Chapters
I. Introduction: Outlines the recent developments in medical malpractice litigation in India and the need for a cohesive approach between judicial principles and medical science.
II. Revolutionizing the present evidential rule of procedure: Discusses the shift from the Bolam to the Bolitho standard and the limitations of relying solely on expert medical testimony.
III. De-limiting the patient’s right to bodily autonomy: Examines informed consent and the necessity of applying a "prudent patient" test to ensure patients are fully aware of medical risks.
IV. Re-designing medicinal practice to equitable innovation: Explores the rise of defensive medicine and illegal drug trials, proposing evidence-based guidelines and "safe harbor" models.
V. Recognizing the need for compliance free package regulations: Addresses the enforceability of package inserts for drugs and the requirement for clinical flexibility based on patient-specific needs.
VI. Conclusion: Summarizes the necessity of an epidemiological approach to evidence assimilation and calls for legislative reform to align medical practices with constitutional standards.
Keywords
Medical Malpractice, Health Care Reform, India, Litigation, Evidence-based Guidelines, Informed Consent, Bodily Autonomy, Defensive Medicine, Clinical Trials, Patient Rights, Vasculitis, Judicial Interpretation, Bolitho Standard, Medical Negligence, Public Health.
Frequently Asked Questions
What is the primary focus of this work?
The work focuses on the evolution of health care reform in India, particularly how medical malpractice litigation is shaping legal and clinical standards.
What are the central thematic fields covered?
The study covers medical jurisprudence, the legal standards for proving negligence, patient autonomy, pharmaceutical regulation, and clinical research methodologies.
What is the core research question?
The research asks how equitable justice and modern medical evidence can be better integrated to address loopholes in the current Indian health care model.
Which scientific and legal methods are employed?
The author uses a combination of medico-legal interpretation and analysis, comparing domestic case law with international precedents such as those from the U.S. and England.
What topics are discussed in the main chapters?
The main sections address the limitations of expert testimony, the doctrine of informed consent, the practice of defensive medicine, and the regulation of drug packaging and clinical trials.
How would you characterize this work through keywords?
The work is defined by terms like medical malpractice, bodily autonomy, evidence-based medicine, and medico-legal reform.
What is the significance of the "Anuradha Saha" judgment in this text?
This judgment serves as the central case study to illustrate the current deficiencies in Indian health care and legal procedures regarding medical negligence.
Why does the author advocate for "Microdosing" or "Phase 0" trials?
The author proposes these as safer, less invasive alternatives to current Phase 1 drug trials, thereby limiting human risk and potential malpractice liability.
What is the "prudent patient" test mentioned in the study?
It is a standard used to determine if a patient has been properly informed of material risks, focusing on what a reasonable person in the patient's position would want to know.
- Quote paper
- Dipayan Chowdhury (Author), 2015, Evolving a new model of Health Care Evaluation in India, Munich, GRIN Verlag, https://www.grin.com/document/313514
